These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 8036712)

  • 21. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
    Coito AJ; Binder J; de Sousa M; Kupiec-Weglinski JW
    Transplantation; 1994 Feb; 57(4):599-605. PubMed ID: 8116048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal inoculation with donor cells in cardiac xenotransplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
    Binder J; Graser E; Hancock WW; Wasowska B; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1995 Dec; 60(12):1516-24. PubMed ID: 8545884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induced tolerance to cardiac allografts with multiple intravenous injection of donor spleen cells].
    Guo HW; Wu QY; Xie SS; Zhang QY; Yang XB; Shao MP
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):664-7. PubMed ID: 15329255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat].
    Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.
    Nakano Y; Monden M; Valdivia LA; Gotoh M; Tono T; Mori T
    Surgery; 1992 Jun; 111(6):668-76. PubMed ID: 1595063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrathymic immunomodulation and the "infectious" tolerance pathway in allograft recipients.
    Reemtsen BL; Kato H; Wang TS; Busuttil RW; Kupiec-Weglinski JW; Goss JA
    J Surg Res; 1999 Jun; 84(1):1-7. PubMed ID: 10334880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.